Report : Middle East and Africa Diet Pills Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Prescription, Over the Counter Drugs, and Herbal Supplements), Application (Appetite Suppression, Fat Blocking, Metabolism Raising Pills, and Others), Age Group (Children and Adults), and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores)
Hospital Pharmacies Segment to Dominate MEA Diet Pills Market During 2021–2028
According to a new market research study on “Middle East & Africa Diet Pills Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Application, Age Group, Distribution Channel, and Country” is expected to reach US$ 81.98 million by 2028 from US$ 46.43 million in 2021. The market is estimated to grow at a CAGR of 8.5% from 2021 to 2028. The report provides trends prevailing in the MEA diet pills market along with the drivers and restraints pertaining to the market growth. Expansion in self-directed care and emerging problem of obesity are the major factor driving the growth of the MEA diet pills market. However, threat in the regulatory environment hinders the growth of MEA diet pills market.
The MEA Diet Pills market is segmented based on product type, application, age group, distribution channel and country. Based on product type, the MEA diet pills market is segmented into prescription, herbal supplements, and over the counter drugs. The prescription segment dominated the MEA diet pills market in 2020. Based on application, the MEA diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. The appetite suppression segment dominated the MEA diet pills market in 2020. Based on age group, MEA diet pills market is segmented into adults, and teenagers. The adults segment dominated the MEA diet pills market in 2020. Based on distribution channel, MEA diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug Stores. The hospital pharmacies segment dominated the MEA diet pills market in 2020. Based on country, the MEA diet pills market is segmented into Saudi Arabia, South Africa, UAE, Rest of MEA. Saudi Arabia segment dominated the MEA diet pills market in 2020.
Pfizer Inc. (Arena Pharmaceutical GMBH); Novo Nordisk A/S; GlaxoSmithKline plc; Lovate Health Sciences International Inc.; TEVA Pharmaceutical Industries LTD; and Chong’s Health Care are among the leading companies in the MEA Diet Pills market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Novo Nordisk A/S received US Food and Drug Administration (FDA) approval for Wegovy (the brand name for once-weekly semaglutide 2.4 mg injection in the US) for chronic weight management. The approval was based on the results from the STEP phase 3a clinical trial programme.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: firstname.lastname@example.org